CVS Stock Jumps as Turnaround Gains Momentum in 2025
CVS Stock Jumps as Turnaround Gains Momentum in 2025 CVS Health Corp. (NYSE: CVS), a long-standing giant in the U.S. healthcare and pharmacy retail sector, is staging a noteworthy comeback. After a turbulent 2024 marked by weak insurance margins, executive changes, and a battered stock price, the company has begun 2025 on stronger footing. With a sharp Q1 earnings beat, improved medical cost…
















